Houses of the Oireachtas

All parliamentary debates are now being published on our new website. The publication of debates on this website will cease in December 2018.

Go to

Written Answers - Medicinal Products

Tuesday, 27 March 2012

Dáil Éireann Debate
Vol. 760 No. 3

First Page Previous Page Page of 500 Next Page Last Page

 17.  Deputy Tom Fleming Information on Tom Fleming Zoom on Tom Fleming  asked the Minister for Health Information on James Reilly Zoom on James Reilly  the steps he will take with the manufacturer of the cancer drug (details supplied) to reduce its price to the Health Service Executive in order that the 200 people per year here who have advanced malignant melanomas, can when applicable, be prescribed this drug by oncologists [16285/12]

Minister for Health (Deputy James Reilly): Information on James Reilly Zoom on James Reilly The HSE’s National Cancer Control Programme has overall responsibility for providing access to appropriate treatments that meet clinical needs, including emerging drug treatments. e drug to which the Deputy refers (Ipilimumab) is a treatment for advanced melanoma in adults. I am advised by the Director of the Cancer Control Programme that this drug is currently going through a health technology assessment process. e Programme has been involved in ongoing discussion with the company on its cost and I am assured that a decision on its use nationally is expected shortly.

Last Updated: 24/08/2015 11:10:35 First Page Previous Page Page of 500 Next Page Last Page